Depression Remission and Response Rates and Anxiety Response as a Predictor of Depression Response in a Community ECT Clinic
VanBronkhorst, S.; Edwards, E.; Saleem, A.; Evans, D.; Achtyes, E.; Nykamp, L.; Sanders, W.
Show abstract
ObjectiveTo assess depression response and remission rates with electroconvulsive therapy (ECT) in a community clinic and to identify factors predicting success in treatment. MethodsWe identified 35 patients by a retrospective chart review with a diagnosis of major depressive disorder or depressive disorder not otherwise specified (according to the Diagnostic and Statistical Manual of Mental Disorders IV-TR) who were treated with an acute series of ECT at the Pine Rest ECT Clinic from March, 2014 to March, 2015. Clinical variables, demographics, depression response rates (based on Patient Health Questionnaire-9; PHQ-9), and anxiety response rates (based on Generalized Anxiety Disorder 7-item) were analyzed. ResultsDepression response (defined as [≥] 50% reduction in PHQ-9 score) and remission rates (defined as final PHQ-9 score < 5) were 54.3% and 31.4%, respectively. This was a highly treatment resistant sample, with an average of 5.3 antidepressant failures prior to initiating ECT. Logistic regression analysis found that depression response rates were predicted by an improvement in anxiety symptoms (odds ratio 1.41; 95% confidence interval, 1.11, 1.78). Additionally, patients with initial severe anxiety scores were less likely than other patients to exhibit a response in depression (p = .027). ConclusionAlmost half of this sample of patients with treatment resistant depression did not respond to ECT in this community-based clinic. Patients who experienced a response in anxiety symptoms were more likely to experience a depression response while those with severe anxiety were less likely to respond.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Pharmacotherapy, drug-drug interactions and potentially inappropriate medication in depressive disorders 94%
- Predicting intentions towards long-term antidepressant use in the management of people with depression in primary care: A longitudinal survey study 94%
- A preliminary study of brain metabolism in treatment-resistant depression before and after treatment with olanzapine-fluoxetine combination 93%
Similar papers in this journal
- Subjective mental health and need for care among psychiatric outpatients during the COVID-19 pandemic: results from an outreach initiative in Sweden 94%
- Development, validation and clinical utility of Short-term AdVerse-effects of Electroconvulsive therapy (SAVE) Checklist 93%
- The recurrence of illness (ROI) index is a key factor in major depression that indicates increasing immune-linked neurotoxicity and vulnerability to suicidal behaviors. 92%
Similar papers in this journal
- Pro-cognitive effects of 5-HT4 receptor agonism in individuals with remitted depression 93%
- Sociodemographic, clinical, and genetic factors associated with self-reported antidepressant response outcomes in the UK Biobank 92%
- A single dose of lamotrigine induces a positive memory bias in healthy volunteers 91%
Similar papers in this journal
- Evaluating the Risk of Psilocybin for the Treatment of Bipolar Depression: A Systematic Review of Published Case Studies 95%
- Anhedonia, Depression, and Symptom Severity in Obsessive-Compulsive Disorder 90%
- Depression polygenic scores are associated with major depressive disorder diagnosis and depressive episode in Mexican adolescents 90%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.